Skin clear gel d / nar. approx. 15% tube 30g
Category
Acne
Release form
Gel
Manufacturer country
Russia
Package quantity, pcs
one
Indications for the use of ICD-10
L71 Rosacea
,
L70.0 Common acne [acne vulgaris]
The drug is intended for external use only.
Avoid getting it on the mucous membrane of the eyes, nose, mouth, as it can cause irritation.
In case of accidental contact of the drug in the eyes, they should be immediately rinsed with running water.
In cases of severe skin irritation in the first weeks of treatment, Skinoclear can be used 1 time / day or the amount of gel applied to the skin can be reduced
short-term drug withdrawal is also possible.
After the symptoms of skin irritation have disappeared, regular use of the drug should be resumed at the recommended dose.
Ermal melasma is insensitive to drug treatment.
A Wood lamp is used for differential diagnostics.
Skinoclear can be used in combination with other acne therapies.
In this case, it is possible to correct the dosage regimen of simultaneously used drugs.
During treatment, it is necessary to protect the skin from the entire spectrum of solar radiation.
Influence on the ability to drive vehicles and work with mechanisms
The drug does not affect driving and engaging in other potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.
Dosage
15% x 30g
Structure
Active substance: azelaic acid - 15.0 g
Excipients: carbomer 980 - 1.0 g, benzoic acid - 0.1 g, disodium edetate dihydrate - 0.1 g, ceramides LS - 0.1 g, isopropyl myristate - 1.0 g, polysorbate-20 -1 , 5 g, propylene glycol - 12.0 g, sodium hydroxide - 0.2 g, water - up to 100.0 g.
Indications
Acne vulgaris rosacea
Side effect
Adverse reactions are presented depending on the frequency of development: very often (1/10 g)
often (> 1/100 to < 1/10)
infrequently (> 1/1000 to < 1/100), rarely (> 1/10000 to < 1/1000), very rare (< 1/10 000), unknown (cannot be estimated based on available data).
Disorders of the skin and subcutaneous fat:
Uncommon: seborrhea, acne, skin depigmentation
Very often: itching, burning, erythema at the site of application
Often: peeling, dry skin, irritation
Rarely: cheilitis.
General disorders and disorders at the injection site:
Uncommon: paresthesia, dermatitis, discomfort, edema at the site of application
Rarely: vesicular eruptions, eczema, warmth, rash at the site of application
Often: pain at the site of application.
Immune system disorders: Rarely: allergic reaction, worsening of bronchial asthma.
As a rule, local skin reactions go away on their own during treatment.
If any of the side effects indicated in the instructions are aggravated, or any other side effects not indicated in the instructions are noted, you should immediately inform your doctor.
INN / Active ingredient
azelaic acid
Interaction with other drugs
The interaction of the drug with other drugs is still not known.
Contraindications
- Hypersensitivity to azelaic acid and other components of the drug
-Children under 12 years old.
APPLICATION DURING PREGNANCY AND DURING BREASTFEEDING
During pregnancy and during breastfeeding, the drug should be used only if the intended benefit to the mother outweighs the possible risk to the fetus and child.
Avoid applying the gel to the breast area before feeding
Storage conditions and periods
At a temperature not higher than 25 degrees.
Specifications
Category
Acne
Release form
Gel
Manufacturer country
Russia
Package quantity, pcs
one
Indications for the use of ICD-10
L71 Rosacea
,
L70.0 Common acne [acne vulgaris]
Vacation conditions
Without recipe
Brand name
Ozone OOO
The amount of the dosage form in the primary package
30 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Acne rash treatment
Anatomical and therapeutic characteristics
D10AX03 Azelanic acid
Dosage form
Gel for external use
Item weight, g
thirty
Expiration date in days
1095
Package weight, g
thirty
Mode of application
:
Outwardly.
The maximum duration of therapy depends on the individual picture of the disease and the severity of the symptoms.
For adults and children over 12 years old, the gel is applied evenly with a thin layer 2 times / day.
(morning and evening) on previously cleansed (mild cleansers and water) and dried areas of the face and, if necessary, the neck and upper chest affected by acne.
For the entire surface of the face, about a 2.5 cm column of gel is sufficient.
The drug should be used regularly throughout the course of treatment, the duration of which depends on the severity of the disease.
In patients with acne vulgaris, a marked improvement is usually seen after 4 weeks.
For best results, the drug should be continued for several months.
If symptoms persist, it is recommended to see a doctor.